home-hero.png hero-amended.png

Search our Government Approved Register to Find your Nearest Accredited Practitioner

Accredited clinics and practitioners

864

All verified against our 116 point assessment process

5 STAR Reviews

56721

Our review system will help you choose the right practitioner for you

Active users

1362945

Who have used Save Face to find safe, qualified practitioners

We’re regularly featured within

Browse Our Treatment Guides

1 /

Every practitioner has passed a rigorous 116 point assessment

Save Face in the news

Why Save Face Verification Matters: 116 Points of Protection for Your Cosmetic Treatment

by

In this short video, Save Face Director Ashton Collins explains why independent verification matters—and why checking your practitioner should always be part of your decision-making process.      
Read more
Why Clinical Oversight Is Mandatory for Medical Weight Loss Injections

by

GLP‑1 receptor agonists (semaglutide: Wegovy®, Ozempic®) and dual GIP/GLP‑1 agents (tirzepatide: Mounjaro®) have transformed medical weight management. But these are prescription medicines with systemic effects requiring medical assessment, baseline testing and ongoing monitoring. People looking for...
Read more
Is My Weight Loss Jab Real? How to Spot Counterfeit Wegovy®, Ozempic® & Mounjaro® Pens in the UK

by

Weight loss injections containing semaglutide, such as Wegovy® and Ozempic®, or tirzepatide, sold as Mounjaro®, are prescription-only medicines in the UK. However, rising demand has created a black market in counterfeit and diverted pens sold through social media, non-medical salons and unregulated ...
Read more
Ozempic Face: Why Your Face Changes After Weight Loss And How To Treat It Safely

by

GLP‑1 medications such as Wegovy® and Ozempic® have helped many people lose significant weight and improve their health. As Ozempic weight loss has become more widely discussed, social media has created a new scare term: Ozempic Face. The phrase suggests the drug is “ruining” people’s faces. In real...
Read more
View more articles

Subscribe to our newsletter to receive the latest news & updates